Pregnancy

TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosing Schedule for BRIUMVI

NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in…

1 month ago

Simbryo Technologies Introduces Personalized Assay to Help IVF Patients Avoid Repeated Failed Transfers

New diagnostic addresses critical gap in IVF care—measuring whether the uterus is ready to support an embryo Study shows test…

1 month ago

Simbryo Technologies Introduces Personalized Assay to Help IVF Patients Avoid Repeated Failed Transfers

New diagnostic addresses critical gap in IVF care—measuring whether the uterus is ready to support an embryo Study shows test…

1 month ago

Simbryo Technologies Introduces Personalized Assay to Help IVF Patients Avoid Repeated Failed Transfers

New diagnostic addresses critical gap in IVF care—measuring whether the uterus is ready to support an embryo Study shows test…

1 month ago

Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches

Brekiya® autoinjector, a new specialty therapy from Amneal, is now available for prescription exclusively through Walgreens Specialty Pharmacy and Sterling…

1 month ago

Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches

Brekiya® autoinjector, a new specialty therapy from Amneal, is now available for prescription exclusively through Walgreens Specialty Pharmacy and Sterling…

1 month ago

Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches

Brekiya® autoinjector, a new specialty therapy from Amneal, is now available for prescription exclusively through Walgreens Specialty Pharmacy and Sterling…

1 month ago

Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference

FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in…

1 month ago

Carrot Launches Carrot Rx ‘Flex Program’ For U.S Employers to Access Even More Cost Savings for Employees

Employers can now implement fertility pharmacy benefits with even more customization, maximizing access to price transparency and cost savings  WEST…

1 month ago

Pacify and Community Care Plan Collaborate to Enhance Maternal Health Support Services

FORT LAUDERDALE, Fla., Oct. 21, 2025 /PRNewswire/ -- Pacify Health, a leading provider of a multimodal maternal health platform offering members…

2 months ago